116 related articles for article (PubMed ID: 28641939)
1. Low-molecular-weight protein tyrosine phosphatase expression as a prognostic factor for men with metastatic hormone-naïve prostate cancer.
Ohtaka M; Miyoshi Y; Kawahara T; Ohtake S; Yasui M; Uemura K; Yoneyama S; Hattori Y; Teranishi JI; Yokomizo Y; Uemura H; Miyamoto H; Yao M
Urol Oncol; 2017 Oct; 35(10):607.e9-607.e14. PubMed ID: 28641939
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Time to Castration-Resistant Prostate Cancer Using Low-Molecular-Weight Protein Tyrosine Phosphatase Expression for Men with Metastatic Hormone-Naïve Prostate Cancer.
Miyoshi Y; Ohtaka M; Kawahara T; Ohtake S; Yasui M; Uemura K; Yoneyama S; Yokomizo Y; Uemura H; Miyamoto H; Yao M
Urol Int; 2019; 102(1):37-42. PubMed ID: 30326476
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular-weight Protein Tyrosine Phosphatase Is a Possible Biomarker for Predicting Postoperative Biochemical Recurrence in Prostate Cancer With Negative Surgical Margins.
Kurose H; Ueda K; Kondo R; Ogasawara S; Kusano H; Sanada S; Naito Y; Akiba J; Kakuma T; Igawa T; Yano H
Anticancer Res; 2019 Feb; 39(2):957-964. PubMed ID: 30711981
[TBL] [Abstract][Full Text] [Related]
4. Importance of metastatic volume in prognostic models to predict survival in newly diagnosed metastatic prostate cancer.
Buelens S; De Bleser E; Dhondt B; Verla W; Decaestecker K; Ost P; Fonteyne V; De Man K; Standaert C; Rottey S; Lumen N
World J Urol; 2019 Dec; 37(12):2565-2571. PubMed ID: 30132067
[TBL] [Abstract][Full Text] [Related]
5. Elevated Expression of EPHA2 Is Associated With Poor Prognosis After Radical Prostatectomy in Prostate Cancer.
Kurose H; Ueda K; Kondo R; Ogasawara S; Kusano H; Sanada S; Naito Y; Nakiri M; Nishihara K; Kakuma T; Akiba J; Igawa T; Yano H
Anticancer Res; 2019 Nov; 39(11):6249-6257. PubMed ID: 31704854
[TBL] [Abstract][Full Text] [Related]
6. Up-regulated expression of low molecular weight protein tyrosine phosphatases in different human cancers.
Malentacchi F; Marzocchini R; Gelmini S; Orlando C; Serio M; Ramponi G; Raugei G
Biochem Biophys Res Commun; 2005 Sep; 334(3):875-83. PubMed ID: 16036221
[TBL] [Abstract][Full Text] [Related]
7. Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy.
Narita S; Nomura K; Hatakeyama S; Takahashi M; Sakurai T; Kawamura S; Hoshi S; Ishida M; Kawaguchi T; Ishidoya S; Shimoda J; Sato H; Mitsuzuka K; Tochigi T; Tsuchiya N; Ohyama C; Arai Y; Nagashima K; Habuchi T
Cancer Med; 2019 Nov; 8(15):6566-6577. PubMed ID: 31508900
[TBL] [Abstract][Full Text] [Related]
8. Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer: Comparing definitions of CHAARTED and LATITUDE trial.
Buelens S; Poelaert F; Dhondt B; Fonteyne V; De Visschere P; Ost P; Verbeke S; Villeirs G; De Man K; Rottey S; Decaestecker K; Lumen N
Urol Oncol; 2018 Apr; 36(4):158.e13-158.e20. PubMed ID: 29336978
[TBL] [Abstract][Full Text] [Related]
9. A possible mechanism of low molecular weight protein tyrosine phosphatase (LMW-PTP) activity modulation by glutathione action during human osteoblast differentiation.
de Souza Malaspina TS; Zambuzzi WF; dos Santos CX; Campanelli AP; Laurindo FR; Sogayar MC; Granjeiro JM
Arch Oral Biol; 2009 Jul; 54(7):642-50. PubMed ID: 19414171
[TBL] [Abstract][Full Text] [Related]
10. Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase.
Taddei ML; Chiarugi P; Cirri P; Buricchi F; Fiaschi T; Giannoni E; Talini D; Cozzi G; Formigli L; Raugei G; Ramponi G
Cancer Res; 2002 Nov; 62(22):6489-99. PubMed ID: 12438242
[TBL] [Abstract][Full Text] [Related]
11. Low-Molecular-Weight Protein Tyrosine Phosphatase Predicts Prostate Cancer Outcome by Increasing the Metastatic Potential.
Ruela-de-Sousa RR; Hoekstra E; Hoogland AM; Souza Queiroz KC; Peppelenbosch MP; Stubbs AP; Pelizzaro-Rocha K; van Leenders GJLH; Jenster G; Aoyama H; Ferreira CV; Fuhler GM
Eur Urol; 2016 Apr; 69(4):710-719. PubMed ID: 26159288
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of the LATITUDE and CHAARTED Risk Criteria for Predicting the Survival of Men with Bone Metastatic Hormone-Naïve Prostate Cancer Treated with Combined Androgen Blockade Therapy: Real-World Data from a Japanese Multi-Institutional Study.
Kawahara T; Yoneyama S; Ohno Y; Iizuka J; Hashimoto Y; Tsumura H; Tabata KI; Nakagami Y; Tanabe K; Iwamura M; Uemura H; Miyoshi Y
Biomed Res Int; 2020; 2020():7804932. PubMed ID: 32714984
[TBL] [Abstract][Full Text] [Related]
13. Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in Japan.
Okamoto T; Hatakeyama S; Narita S; Takahashi M; Sakurai T; Kawamura S; Hoshi S; Ishida M; Kawaguchi T; Ishidoya S; Shimoda J; Sato H; Mitsuzuka K; Tochigi T; Tsuchiya N; Arai Y; Habuchi T; Ohyama C
World J Urol; 2019 Sep; 37(9):1827-1835. PubMed ID: 30511214
[TBL] [Abstract][Full Text] [Related]
14. [The subgroup analysis of the prognostic value of the intraductal carcinoma of the prostate in patients with metastatic prostate cancer].
Zhao JG; Nie L; Chen XQ; Chen N; Zeng H
Zhonghua Wai Ke Za Zhi; 2019 Jun; 57(6):422-427. PubMed ID: 31142066
[No Abstract] [Full Text] [Related]
15. Total Knockdown of LMW-PTP in MDA-MB-231 Cells Reduces Osteoclastogenesis.
Sapinho G; Alho I; Bicho M; Coelho C
Anticancer Res; 2017 Dec; 37(12):6671-6677. PubMed ID: 29187443
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight protein tyrosine phosphatase: Multifaceted functions of an evolutionarily conserved enzyme.
Caselli A; Paoli P; Santi A; Mugnaioni C; Toti A; Camici G; Cirri P
Biochim Biophys Acta; 2016 Oct; 1864(10):1339-55. PubMed ID: 27421795
[TBL] [Abstract][Full Text] [Related]
17. The role of low-molecular-weight protein tyrosine phosphatase (LMW-PTP ACP1) in oncogenesis.
Alho I; Costa L; Bicho M; Coelho C
Tumour Biol; 2013 Aug; 34(4):1979-89. PubMed ID: 23584899
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight protein tyrosine phosphatase isoforms regulate breast cancer cells migration through a RhoA dependent mechanism.
Alho I; Costa L; Bicho M; Coelho C
PLoS One; 2013; 8(9):e76307. PubMed ID: 24086724
[TBL] [Abstract][Full Text] [Related]
19. Osteoblast adhesion dynamics: a possible role for ROS and LMW-PTP.
Fernandes GV; Cavagis AD; Ferreira CV; Olej B; Leão Mde S; Yano CL; Peppelenbosch M; Granjeiro JM; Zambuzzi WF
J Cell Biochem; 2014 Jun; 115(6):1063-9. PubMed ID: 24123071
[TBL] [Abstract][Full Text] [Related]
20. Exploring the effect of aplidin on low molecular weight protein tyrosine phosphatase by molecular docking and molecular dynamic simulation study.
Sun YZ; Wu JW; Lu XH; Ma Y; Wang RL
Comput Biol Chem; 2019 Dec; 83():107123. PubMed ID: 31561070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
